A bispecific nanobody targeting the dimerization interface of epidermal growth factor receptor: Evidence for tumor suppressive actions in vitro and in vivo-Reference-Cited by-同舟云学术

A bispecific nanobody targeting the dimerization interface of epidermal growth factor receptor: Evidence for tumor suppressive actions in vitro and in vivo

Published:2021-04 Issue: Volume:548 Page:78-83
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Xu Zhimin^ORCID,Qiu Chuangnan,Wen Biyan,Wang Shuang,Zhu Linfeng,Zhao Lin,Li Huangjin^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference33 articles.

1. Epidermal growth factor receptor cell proliferation signaling pathways;Wee;Cancers,2017

2. Mechanisms of receptor tyrosine kinase activation in cancer;Du;Mol. Canc.,2018

3. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers;Roskoski;Pharmacol. Res.,2019

4. EGFR-TKIs resistance via EGFR-independent signaling pathways;Liu;Mol. Canc.,2018

5. Broad RTK-targeted therapy overcomes molecular heterogeneity-driven resistance to cetuximab via vectored immunoprophylaxis in colorectal cancer;Hu;Canc. Lett.,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and functional insight into anti-EGFR nanobody: Theranostic implications for malignancies;Life Sciences;2024-05

2. Advances in Metabolic Engineering of Pichia pastoris Strains as Powerful Cell Factories;Journal of Fungi;2023-10-19

3. Bi-Specific Killer Cell Engager Enhances NK Cell Activity against Interleukin-13 Receptor Alpha-2 Positive Gliomas;Cells;2023-06-25

4. Identification and characterization of blocking nanobodies against human CD70;Acta Biochimica et Biophysica Sinica;2022-10-01

5. Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment;Frontiers in Immunology;2022-01-18